Theravance Biopharma, Inc. (TBPH)
TBPH · Pharmaceutical Preparations · George Town, Grand Cayman, CA · filing with the SEC since 2013
Grade6.3
◀ Past 5.6● Present 7.4▶ Future 5.4
Who owns Theravance Biopharma, Inc.
As filed with the SECHolders of 5% or more
2
Madison Avenue International LP holds 17.7% of Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares"), as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
11
report now, of 35 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Madison Avenue International LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares")
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 30, 2025 · Common Stock
Newtyn Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Share $0.00001 par value · reported falling below 5%, from 8.5% in Feb 17, 2026
Weiss Asset Management LP
SCHEDULE 13D/A · filed Sep 25, 2026 · Ordinary Share $0.00001 Par Value · reported falling below 5%, from 14.5% in Mar 25, 2026
What TBPH reports owning in othersstakes of 5% or more, and other ties
5 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 23, 2026.
Insider tradesForm 4
20sales
0purchases
14sales on a scheduled plan
2people selling
$3.9Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 40 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Samaha Eli | 10% owner | 5 | $5.9M | 0 | 0 | $0 |
| Broshy Eran | director | 8 | $2.5M | 2 | 0 | $0 |
| Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 12 | $1.5M | 12 | 0 | $0 |